If you or a loved one has suffered from cancer or other health complications after taking Zantac, contact the award-winning attorneys at Davis Law Group today to request a free case review. We can help you better understand your legal rights and options for receiving compensation for your injuries, medical bills, pain & suffering, and other damages. Call (206) 727-4000 today to get started.
Millions of patients across the United States have been prescribed the popular heartburn drug Zantac, or even taken the over-the-counter version of the drug. But drug makers often prioritize profits over patient safety, and the early data is showing a similar pattern with regard to Zantac.
The defective drug legal team at Davis Law Group is investigating injury claims from patients who have been prescribed and taken Zantac. Studies show that Zantac contains high levels of carcinogenic chemicals which may contribute to a patient’s increased risk of being diagnosed with various types of cancer.
When Zantac was still in development and going through a standard FDA trial phase, testing showed that a single tablet of Zantac could contain thousands of times the FDA-approved level of N‑nitrosodimethylamine (NDMA), which is a known carcinogen. Experts contend that Sanofi, manufacturer of Zantac, concealed the fact that the drug could increase the risk of patients being diagnosed with cancer.
FDA Issues Zantac Recall After Reports of Cancer Risk
In September 2019, the U.S. Food and Drug Administration announced that it would conduct a thorough investigation into a possible link between Zantac medication and the risk of cancer to heartburn patients who were prescribed or otherwise taking the drug. This came after independent test results found that Zantac samples contained dangerously high levels of NDMA.
Zantac, which is the brand name for the medicine ranitidine hydrochloride, is prescribed to patients with chronic heartburn and is meant to reduce the buildup of stomach acid which can lead to acid reflux, severe heartburn, and other related gastrointestinal issues. Patients who were prescribed Zantac were not made aware by the drug’s manufacturer that the drug could increase the risk of cancer.
In some studies, the presence of NDMA in Zantac were found to be up to 3,000 times higher than the FDA’s recommended intake limit of NDMA, which is 96 nanograms per day. The highest reported amount of NDMA found in Zantac is more than 2,500,000 nanograms.
Bellwether Lawsuit Filed in 2019
The first Zantac bellwether lawsuit was filed in October 2019 on behalf of plaintiff Mark Allan Blake, who was diagnosed with an aggressive form of bladder cancer after having taken Zantac drugs for many years. Blake alleges that Pfizer Pharmaceuticals Inc. and Sanofi failed to warn him and other patients of the cancer risk associated with taking the popular heartburn drug.
That lawsuit is pending, and the outcome could dictate the legal options for other patients affected by the lawsuit moving forward. These bellwether trials often set a strong legal precedent for whether or not other patients affected by the same defective product are eligible for compensation for their injuries and other damages.
Contact A Qualified Attorney Today To Get Started With Your Claim
The award-winning legal team at Davis Law Group works with firms across the United States on defective drug and medical device litigation. We have helped countless patients get the fair compensation they deserve after suffering at the hands of corporations that prioritize profit over patient safety.
Contact us today to request a free case review and to learn more about your legal rights and options for filing a claim. There are no up-front costs associated with hiring an attorney for a Zantac cancer claim, and clients do not owe any attorney’s fees until we have successfully recovered compensation on their behalf. Call (206) 727-4000 or use the confidential contact form on this page to request a free case review.
